Presentation is loading. Please wait.

Presentation is loading. Please wait.

輸血後疑似TRALI案例報告 台中榮民總醫院病理檢驗部 血庫 謝獻旭.

Similar presentations


Presentation on theme: "輸血後疑似TRALI案例報告 台中榮民總醫院病理檢驗部 血庫 謝獻旭."— Presentation transcript:

1 輸血後疑似TRALI案例報告 台中榮民總醫院病理檢驗部 血庫 謝獻旭

2

3 Case Presentation (1) MER case Chief complaint Present illness
Admission Date 99/03/19 Age 54 year(s) old Female Chief complaint Acute onset of persistent Gum bleeding for 4-5 days Present illness Increased episodes of common cold in recent months Fatique, weakness, sorethroat, and poor appetite developed she noted that she has ecchymosis easily after trauma.(搥背後會有瘀青) for weeks In recent one week, sudden onset of persistent gum bleeding was noted Past history Hypertension under regular medication HBV carrier

4 Lab. Data (1) CBC: Other’s DIC profiles (+)
leukocytosis(WBC=15100/cumm), anemia(Hb=7.7 g/dl), and thrombocytopenia(plt=10000/cumm) DC:Blast: 2%, promyelocyte: 69%, myelocyte: 4%, meta.: 1%, band: 2%, segment: 8%, lymphocyte: 13%, monocyte: 1% Other’s DIC profiles (+) Prothrombin time : ( C: 10.3 SEC P: SEC) INR: R ( ); APTT : ( C: 27.4 SEC P: SEC) ( ) D-Dimer : ug/L D.D.U ( < 324 ug/L D.D.U) Fibrinogen < 100

5 Lab. Data (2) CRP: 12.16 mg/dL ( < 0.3 mg/dL)
LDH: U/l ( ) BM aspiration & biopsy: acute promyelocytic leukemia Flow cytometry: CD33(+); HLDR (-) Meta-phase cytogenetic data: t(15;17)

6 Hospital Course Diagnosis: Acute promyelocytic leukemia (FAB classification: M3) Initial treatment: All-trans-retinoid acid (ATRA)(dose :45mg/m2 /day) Blood transfusion: 2 Unit packed RBC 8 Units FFP + 1 unit Plateletpheresis After blood transfusion she suffered from acute onset of dyspnea hypoxia and hypotension Transfer to ICU

7 CXR Before Transfusion After Transfusion
Chest X ray looks like ARDS(Acute Respiratory Distress Syndrome )

8 TRALI Definition New ALI:
Acute onset Hypoxia O2sat≦90% on room air Bilateral infiltrates on frontal chest radiograph No evidence of atrial hypertension Onset of symptoms within 6 hours of transfusion No preexisting ALI before transfusion

9 TRALI:What are the triggers?

10 Leukocyte Antigens Implicated in TRALI
Leukoagglutinins HLA antibodies Neutrophil-specific antibodies Human Neutrophil Antigens HNA-1 (1a, 1b, 1c) HNA-2 HNA-3 (3a,2009) HNA-4 (2009) HNA-5 (2009) Human Leukocyte Antigens HLA Class I HLA Class II

11 Bioactive Lipids Accumulate during the storage of cellular blood products (lysophosphatidylcholine, L-PC) Prime neutrophils: primed neutrophils have a greater response to activating agents Enhance neutrophil-mediated lung injury in animal models Prospective and retrospective studies have found greater levels of bioactive lipids in TRALI implicated units or post-transfusion sera from TRALI patients than controls Silliman et al. Transfusion. 1997;37:719-26 Silliman et al. Blood. 2003;101:454-62

12 Levels increase in stored platelets Primes neutrophils
Soluble CD40L Released by platelets Levels increase in stored platelets Primes neutrophils Inhibition of CD40-CD40L system reduces acute lung injury in animal models A case-control study found higher sCD40L levels in TRALI-implicated units than in control units Khan et al. Blood. 2006;108:

13 Clinical Management Stop the transfusion Respiratory Support
Supplemental oxygen Mechanical ventilation Pressor agents Rule out of other causes of respiratory distress No evidence of role for diuretics or steroid

14 TRALI: Clinical Course
Symptoms generally resolve in 24 to 48 hours Symptoms may resolve before diagnosis is made Mortality 10% to 50% Moore SB. Critical Care Medicine 2006; 34: S Rana R et al. Transfusion 2006;46:

15 Patient Factors TRALI is more common in Surgery patients
Patients with hematological malignancies and cardiac disease Moore. Crit Care Med 2006; 34: S114-S117 Silliman et al. Blood 2003; 101:

16 TRALI:Most Frequently Implicated Blood Product
Red Blood Cells Fresh Frozen Plasma Platelet Concentrates Apheresis Platelets

17 SHOT Annual Report 2009

18 SHOT Annual Report 2009

19 There is no diagnostic test for TRALI and it is easily confused with other causes of acute lung injury, circulatory overload or infection

20 TRALI (Transfusion-Related Acute Lung Injury )
TACO (Transfusion-Associated Circulatory Overload )

21 TACO (Transfusion-Associated Circulatory Overload )
在短時間內輸血量超過病人生理之耐受量 易發生於: 慢性貧血而血液體積正常者 老年者 心臟功能不佳者 Acute respiratory distress Acute or worsening pulmonary edema Evidence of positive fluid balance. Tachycardia Increased blood pressure

22 TRALI (Transfusion-Related Acute Lung Injury )
TACO (Transfusion-Associated Circulatory Overload ) ATRA syndrome

23 臨床發現以all-trans-retinoic acid (簡稱ATRA) 治療APL可達高緩解率,並可減少出血性併發症。
All-trans-retinoid acid (ATRA) 臨床發現以all-trans-retinoic acid (簡稱ATRA) 治療APL可達高緩解率,並可減少出血性併發症。 2 doses of ATRA 2 doses of ATRA 2 doses of ATRA

24 ATRA syndrome is an unpredictable but frequent complication of the use of ATRA to treat APL. Prominent respiratory distress with concurrent symptoms that are often less immediately appreciable, may lead to the misdiagnosis JASON P. et al Psychosomatics :

25 Diagnosis of ATRA syndrome
association of at least three of the following signs weight gain fever respiratory distress lung infiltrates pleural or pericardial effusion hypotension renal failure S de Botton et al Leukemia (2003) 17, 339–342.

26 CXR (after steroid treatment)
99/03/22 99/03/23 99/03/26

27 TRALI (Transfusion-Related Acute Lung Injury )
TACO (Transfusion-Associated Circulatory Overload ) ATRA syndrome Atypical pneumonia

28 Discussion TRALI => Steroid +通報捐血中心 TACO => Diuretics + ICU
ATRA syndrome => Steroid + DC drug Atypical pneumonia=> Antibiotics

29 Thank You!!


Download ppt "輸血後疑似TRALI案例報告 台中榮民總醫院病理檢驗部 血庫 謝獻旭."

Similar presentations


Ads by Google